Security key
04216R102
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)
CUSIP: 04216R102
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 1,234,381
- Total 13F value
- $2,061,949
- Share change
- -68,943
- SEC-reported price per share
- $1.67
- Number of holders
- 21
- Value change
- -$89,077
- Number of buys
- 3
- Number of sells
- 12
- Shares outstanding
- 67,070,688
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
21
Top holders
10
ARMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Armata Pharmaceuticals, Inc. SEC filings
Armata Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04216R102
Recent filing periods:
Ownership snapshot
Top reported holders of ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BANK OF AMERICA CORP /DE/
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 0.95%
Showing 1-6 of 15 holder rows.
Quick read
BANK OF AMERICA CORP /DE/ leads the comparable SEC ownership view at 0.95%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BANK OF AMERICA CORP /DE/'s linked filing trail.
Comparable ownership
Top 5
BANK OF AMERICA CORP /DE/
0.95%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
0.29%
EDGEWOOD MANAGEMENT LLC
0.15%
RENAISSANCE TECHNOLOGIES LLC
0.11%
VANGUARD GROUP INC
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.95%
|
$786,711
634,444 shares
|
— | 31 Dec 2022 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.29%
|
$240,166
193,682 shares
|
— | 31 Dec 2022 |
| EDGEWOOD MANAGEMENT LLC |
13F
Company
|
0.15%
|
$124,000
100,000 shares
|
— | 31 Dec 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.11%
|
$91,000
73,696 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
0.07%
|
$54,305
43,795 shares
|
— | 31 Dec 2022 |
| HRT FINANCIAL LP |
13F
Company
|
0.06%
|
$52,000
42,277 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
1,234,381
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2026 Across Filers
Q1 2026 holders
44
Q1 2023 holders
21
Holder diff
-23
| Investor | Q1 2026 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend